Login / Signup

Blinded sample size reestimation in event-driven clinical trials: Methods and an application in multiple sclerosis.

Tim FriedeHarald PohlmannHeinz Schmidli
Published in: Pharmaceutical statistics (2019)
Keyphrases
  • multiple sclerosis
  • clinical trial
  • study protocol
  • white matter
  • placebo controlled
  • phase ii
  • double blind
  • open label
  • phase iii